KLRS insider buying
Kalaris Therapeutics, Inc.
Every qualifying open-market purchase of KLRS reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in KLRS yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in KLRS
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
KLRS insider buying — FAQ
- Are insiders buying KLRS stock?
- 2 insiders have bought KLRS (Kalaris Therapeutics, Inc.) on the open market, most recently on May 22, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much KLRS stock have insiders bought?
- Insiders have bought a combined $6.2M of KLRS across 2 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in KLRS?
- A cluster buy is two or more distinct Kalaris Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying KLRS on the open market within a rolling window. None has been detected in KLRS yet.
- Where does this KLRS insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in KLRS
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy KLRS within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding KLRS.